U.S. market Closed. Opens in 1 day 9 hours 28 minutes

ATHA | Athira Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue969.00K1.05M479.00K2.00MN/AN/A
Gross Profit-969.00K-1.05M-479.00K-2.00MN/AN/A
Operating Expenses125.47M88.86M55.19M18.67M4.70M5.01M
Selling, General & Admin33.30M32.55M21.23M6.71M1.66M1.42M
Research & Development93.79M61.46M42.79M13.29M3.79M3.59M
Other Operating Expenses-1.63M-5.16M-8.84M-1.32M-754.00K-164.00K
Operating Income-125.47M-104.02M-64.02M-20.00M-5.45M-5.01M
Other Expenses / Income7.79M8.38M9.17M40.00K288.00K-88.00K
Before Tax Income-117.67M-95.64M-54.85M-19.95M-5.16M-5.10M
Income Tax ExpensesN/A-8.38M-479.00K-1.32M-459.00K-76.00K
Net Income-117.67M-87.26M-54.37M-18.63M-4.70M-5.10M
Interest ExpensesN/A24.32M3.00K367.00K346.00K9.00K
Basic Shares Outstanding38.02M37.73M36.92M32.49M32.62M6.19M
Diluted Shares Outstanding38.02M37.73M36.92M32.49M32.62M6.19M
EBITDA-116.70M-94.59M-54.37M-19.01M-4.82M-79.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-117.67M-71.32M-54.85M-19.59M-4.82M-5.16M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙